Scientific Results

Evidence for a multivalent effect in inhibition of sulfatases involved in lysosomal storage disorders (LSDs)

Year: 2016

Authors: D’Adamio G., Matassini C., Parmeggiani C., Catarzi S., Morrone A., Goti A., Paoli P., Cardona F.

Autors Affiliation: ‎Univ Florence, Dept Chem Ugo Schiff, Via Lastruccia 3-13, I-50019 Sesto Fiorentino, FI, Italy; CNR, INO, Via N Carrara 1, I-50019 Sesto Fiorentino, FI, Italy; LENS, Via N Carrara 1, I-50019 Sesto Fiorentino, FI, Italy;‎ Univ Florence, Dept Neurosci Pharmacol & Child Hlth, Meyer Childrens Hosp, Paediat Neurol Unit & Labs,Neurosci Dept, Viale Pieraccini 24, I-50139 Florence, Italy; Univ Florence, Dept Expt & Clin Biomed Sci, Viale Morgagni 50, I-50134 Florence, Italy

Abstract: Two newly synthesized nonavalent polyhydroxylated pyrrolidine iminosugars are the first examples of multivalent inhibitors of GALNS and IDS lysosomal enzymes, whose deficiency leads to Morquio A syndrome and Hunter disease, respectively, and pave the way to a pharmacological chaperone or stabilizing enzyme therapy for these LSDs.

Journal/Review: RSC ADVANCES

Volume: 6 (69)      Pages from: 64847  to: 64851

KeyWords: ENZYME REPLACEMENT THERAPY; IMINOSUGAR CLICK CLUSTERS; PHARMACOLOGICAL CHAPERONES; GAUCHER-DISEASE; HYACINTHACINE A(2); DIAGNOSIS; MORQUIO; GLUCOCEREBROSIDASE; 7-DEOXYCASUARINE; ARCHITECTURES
DOI: 10.1039/c6ra15806d

Citations: 10
data from “WEB OF SCIENCE” (of Thomson Reuters) are update at: 2021-10-17
References taken from IsiWeb of Knowledge: (subscribers only)
Connecting to view paper tab on IsiWeb: Click here
Connecting to view citations from IsiWeb: Click here

gdpr-image
This site uses cookies. If you decide to continue browsing we consider that you accept their use. For more information about cookies and how to delete them please read our Info Policy on cookies use.
Read more